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In the last decades head and neck cancer incidence has
risen in the elderly (>70 years) as a consequence of the
increased average lifespan.
Two main mechanisms have been suggested to explain
the increase in cancer incidence with ageing: the first
refers to prolonged exposure to carcinogens during life
and the second explanation seems to be attributed to
the individual vulnerability to cancer with age.
To suppress the development of cancer two main stra-
tegies are involved: one uses Caretaker proteins to pro-
tect genome from mutations and the other uses
Gatekeeper proteins to eliminate or prevent the growth
of mutated cells.
Recently studies on ageing have shown a correlation
between ageing and an increase in the mitochondrial
production of Reactive Oxigen Species (ROS) and
between mitochondrial function decline age –associate
and mitochondrial DNA (mtDNA) mutations.
Mitochondrial DNA mutations have been found to be
implicated in the head and neck cancer multistep
process.
So, future strategies that prevent mtDNA damage or
improve DNA-repair mechanisms are likely to decrease
susceptibility to cancer with age.
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